Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 42 studies | 37% ± 13% | |
| endothelial cell of lymphatic vessel | 26 studies | 56% ± 16% | |
| endothelial cell of vascular tree | 14 studies | 33% ± 13% | |
| endothelial cell of artery | 13 studies | 30% ± 15% | |
| vein endothelial cell | 13 studies | 42% ± 18% | |
| ciliated cell | 12 studies | 31% ± 11% | |
| capillary endothelial cell | 12 studies | 35% ± 14% | |
| microglial cell | 6 studies | 29% ± 10% | |
| basal cell | 5 studies | 30% ± 8% | |
| pericyte | 5 studies | 33% ± 12% | |
| regulatory T cell | 5 studies | 19% ± 4% | |
| pro-B cell | 4 studies | 35% ± 12% | |
| fibroblast | 4 studies | 29% ± 17% | |
| B cell | 3 studies | 17% ± 3% | |
| T cell | 3 studies | 16% ± 1% | |
| classical monocyte | 3 studies | 28% ± 6% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 23% ± 6% | |
| conventional dendritic cell | 3 studies | 34% ± 22% | |
| glomerular endothelial cell | 3 studies | 32% ± 3% | |
| plasma cell | 3 studies | 21% ± 5% | |
| epithelial cell | 3 studies | 31% ± 10% | |
| dendritic cell | 3 studies | 47% ± 35% | |
| macrophage | 3 studies | 31% ± 17% | |
| lymphocyte | 3 studies | 34% ± 17% | |
| endothelial cell of sinusoid | 3 studies | 42% ± 32% | |
| astrocyte | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 5761.23 | 459 / 459 | 100% | 47.51 | 1113 / 1118 |
| esophagus | 100% | 3391.30 | 1444 / 1445 | 99% | 59.17 | 182 / 183 |
| lung | 100% | 3771.21 | 577 / 578 | 99% | 48.71 | 1148 / 1155 |
| thymus | 100% | 4699.44 | 653 / 653 | 99% | 59.54 | 599 / 605 |
| uterus | 100% | 4692.84 | 170 / 170 | 97% | 45.17 | 445 / 459 |
| bladder | 100% | 2947.52 | 21 / 21 | 97% | 35.54 | 487 / 504 |
| intestine | 99% | 2749.60 | 953 / 966 | 95% | 28.59 | 503 / 527 |
| prostate | 100% | 2537.02 | 244 / 245 | 94% | 21.61 | 471 / 502 |
| skin | 98% | 4281.06 | 1781 / 1809 | 94% | 48.92 | 446 / 472 |
| stomach | 93% | 1558.45 | 333 / 359 | 96% | 35.18 | 274 / 286 |
| kidney | 97% | 2049.47 | 86 / 89 | 90% | 46.25 | 813 / 901 |
| ovary | 94% | 1552.97 | 169 / 180 | 93% | 22.81 | 399 / 430 |
| adrenal gland | 100% | 1978.00 | 257 / 258 | 87% | 27.93 | 199 / 230 |
| pancreas | 52% | 493.69 | 170 / 328 | 98% | 53.62 | 174 / 178 |
| brain | 50% | 555.61 | 1325 / 2642 | 89% | 23.83 | 629 / 705 |
| adipose | 100% | 6404.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 49.30 | 29 / 29 |
| spleen | 100% | 3754.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 46.89 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.53 | 1 / 1 |
| blood vessel | 98% | 3093.94 | 1307 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 1973.76 | 842 / 861 | 0% | 0 | 0 / 0 |
| liver | 25% | 229.66 | 56 / 226 | 65% | 12.11 | 264 / 406 |
| eye | 0% | 0 | 0 / 0 | 60% | 11.06 | 48 / 80 |
| peripheral blood | 53% | 605.02 | 493 / 929 | 0% | 0 | 0 / 0 |
| muscle | 49% | 484.24 | 395 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001525 | Biological process | angiogenesis |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0007165 | Biological process | signal transduction |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0042060 | Biological process | wound healing |
| GO_0030154 | Biological process | cell differentiation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0032422 | Molecular function | purine-rich negative regulatory element binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ELK3 |
| Protein name | ETS transcription factor ELK3 ELK3, ETS-domain protein (SRF accessory protein 2), isoform CRA_b (ETS transcription factor ELK3) ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2) |
| Synonyms | SAP2 NET hCG_32371 |
| Description | FUNCTION: May be a negative regulator of transcription, but can activate transcription when coexpressed with Ras, Src or Mos. Forms a ternary complex with the serum response factor and the ETS and SRF motifs of the Fos serum response element. |
| Accessions | F8VUJ0 ENST00000228741.8 F8VZQ0 P41970 ENST00000549985.1 ENST00000552142.5 ENST00000547249.1 H0YIH6 G3V1Z7 ENST00000547860.1 |